Androprostamines A and B, the new anti-prostate cancer agents produced by Streptomyces sp. MK932-CF8.
J Antibiot (Tokyo)
; 68(4): 279-85, 2015 Apr.
Article
en En
| MEDLINE
| ID: mdl-25269460
ABSTRACT
Androgen receptor (AR) is a validated target in all clinical states of prostate cancer. Androprostamines A and B, the new inhibitors of androgen receptor, were isolated from Streptomyces sp. MK932-CF8. Their structures were determined by the spectroscopic analysis, degradation studies and synthesis. Androprostamines showed potent inhibitory effect against androgen-dependent growth of human prostate cancer cells without cytotoxicity and repressed the androgen-induced expression of AR-regulated genes.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Neoplasias de la Próstata
/
Streptomyces
/
Antagonistas de Receptores Androgénicos
/
Antineoplásicos
Límite:
Humans
/
Male
Idioma:
En
Revista:
J Antibiot (Tokyo)
Año:
2015
Tipo del documento:
Article
País de afiliación:
Japón